LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10

Search options

  1. Article ; Online: Quantitative microcapillary electrophoresis immunoassay (mCE IA) for end-to-end analysis of pertactin within in-process samples and Quadracel® vaccine.

    Keizner, Diana / Ghaffari, Shakiba / Beheshti, Samaneh / Newman, Elena / Tulumello, David / Kirkitadze, Marina / Leach, Michael

    Journal of pharmaceutical and biomedical analysis

    2021  Volume 204, Page(s) 114284

    Abstract: Protein concentration is an important attribute in the production of subunit or component-based vaccine antigens. Rigorous monitoring of protein concentration is required to identify potential areas for yield improvement. The current GMP method for ... ...

    Abstract Protein concentration is an important attribute in the production of subunit or component-based vaccine antigens. Rigorous monitoring of protein concentration is required to identify potential areas for yield improvement. The current GMP method for quantitation is the plate-based ELISA which requires numerous hands-on steps and has low sensitivity in comparison to new microfluidic systems. To address this issue, a sensitive automated microCapillary Electrophoresis ImmunoAssay (mCE IA) method was developed to accurately separate and quantitate pertactin (PRN), an important antigen of the modern acellular Pertussis (aP) vaccine. PRN is reported to be a low-yielding antigen; thus, it is critical to observe its concentration throughout its manufacturing process. First, a primary antibody for PRN was identified to establish suitable immunoprobing conditions for detection of PRN over a wide linear dynamic range that spans 3 orders of magnitude. Next, the pre-adsorbed PRN Drug Substance (DS) was used as a reference standard to quantitate PRN samples against a calibration curve with adequate accuracy and precision. Four representative samples including three in-process steps and final adjuvanted drug product: Quadracel®, were examined to demonstrate the capability of mCE IA to quantitate PRN with high sensitivity and specificity. The matrices of the selected samples contain additional components (e.g. other proteins, growth factors, cell culture media, residual ammonium sulfate, and aluminum adjuvant) often making the quantitation of PRN challenging. The specificity and method linearity were demonstrated by spiking pre-adsorbed PRN DS into the four representative samples. In addition, it was shown that reportable concentrations of PRN for nine downstream process steps as analyzed by our method is comparable to concentrations obtained with ELISA. Most importantly, this study demonstrated that our method's quantitative accuracy is independent of matrix components, as each sample undergoes extensive dilution. This allows for seamless end-to-end analysis of PRN from fermenter harvest, through to complex downstream process samples to adjuvanted drug products. Finally, for the first time the developed and qualified mCE IA method was shown to quantify PRN throughout the entire manufacturing process to provide rapid feedback for process optimizations allowing for accurate yield and step-loss calculations.
    MeSH term(s) Bacterial Outer Membrane Proteins ; Bordetella pertussis ; Electrophoresis ; Pertussis Vaccine ; Virulence Factors, Bordetella
    Chemical Substances Bacterial Outer Membrane Proteins ; Pertussis Vaccine ; Virulence Factors, Bordetella ; pertactin (63GD90PP8X)
    Language English
    Publishing date 2021-07-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 604917-5
    ISSN 1873-264X ; 0731-7085
    ISSN (online) 1873-264X
    ISSN 0731-7085
    DOI 10.1016/j.jpba.2021.114284
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: 27

    Khatun, Rahima / Hunter, Howard N / Sheng, Yi / Carpick, Bruce W / Kirkitadze, Marina D

    Journal of pharmaceutical and biomedical analysis

    2018  Volume 159, Page(s) 166–172

    Abstract: A novel qNMR method is described for the quantitative determination of total aluminum and phosphate in aluminum phosphate ( ... ...

    Abstract A novel qNMR method is described for the quantitative determination of total aluminum and phosphate in aluminum phosphate (AlPO
    MeSH term(s) Adjuvants, Immunologic/analysis ; Adjuvants, Immunologic/chemistry ; Aluminum/analysis ; Aluminum Compounds/analysis ; Aluminum Compounds/chemistry ; Drug Compounding ; Magnetic Resonance Spectroscopy/methods ; Phosphates/analysis ; Phosphates/chemistry ; Phosphorus/analysis ; Vaccines/analysis ; Vaccines/chemistry
    Chemical Substances Adjuvants, Immunologic ; Aluminum Compounds ; Phosphates ; Vaccines ; Phosphorus (27YLU75U4W) ; Aluminum (CPD4NFA903) ; aluminum phosphate (F92V3S521O)
    Language English
    Publishing date 2018-06-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 604917-5
    ISSN 1873-264X ; 0731-7085
    ISSN (online) 1873-264X
    ISSN 0731-7085
    DOI 10.1016/j.jpba.2018.06.025
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Tuberculosis vaccine candidate: Characterization of H4-IC31 formulation and H4 antigen conformation.

    Deshmukh, Sasmit S / Magcalas, Federico Webster / Kalbfleisch, Kristen N / Carpick, Bruce W / Kirkitadze, Marina D

    Journal of pharmaceutical and biomedical analysis

    2018  Volume 157, Page(s) 235–243

    Abstract: Tuberculosis (TB) is one of the leading causes of death worldwide, making the development of effective TB vaccines a global priority. A TB vaccine consisting of a recombinant fusion protein, H4, combined with a novel synthetic cationic adjuvant, ... ...

    Abstract Tuberculosis (TB) is one of the leading causes of death worldwide, making the development of effective TB vaccines a global priority. A TB vaccine consisting of a recombinant fusion protein, H4, combined with a novel synthetic cationic adjuvant, IC31
    MeSH term(s) Adjuvants, Immunologic/chemistry ; Chemistry, Pharmaceutical/methods ; Oligodeoxyribonucleotides/chemistry ; Particle Size ; Recombinant Fusion Proteins/chemistry ; Spectrum Analysis/methods ; Tuberculosis/immunology ; Tuberculosis Vaccines/chemistry ; Tuberculosis Vaccines/immunology
    Chemical Substances Adjuvants, Immunologic ; Oligodeoxyribonucleotides ; Recombinant Fusion Proteins ; Tuberculosis Vaccines
    Language English
    Publishing date 2018-05-31
    Publishing country England
    Document type Journal Article
    ZDB-ID 604917-5
    ISSN 1873-264X ; 0731-7085
    ISSN (online) 1873-264X
    ISSN 0731-7085
    DOI 10.1016/j.jpba.2018.05.048
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.

    Kirkitadze, Marina D / Kowalska, Anna

    Acta biochimica Polonica

    2005  Volume 52, Issue 2, Page(s) 417–423

    Abstract: The deposition of aggregated amyloid beta-protein (Abeta) in the human brain is a major lesion in Alzheimer' disease (AD). The process of Abeta fibril formation is associated with a cascade of neuropathogenic events that induces brain neurodegeneration ... ...

    Abstract The deposition of aggregated amyloid beta-protein (Abeta) in the human brain is a major lesion in Alzheimer' disease (AD). The process of Abeta fibril formation is associated with a cascade of neuropathogenic events that induces brain neurodegeneration leading to the cognitive and behavioral decline characteristic of AD. Although a detailed knowledge of Abeta assembly is crucial for the development of new therapeutic approaches, our understanding of the molecular mechanisms underlying the initiation of Abeta fibril formation remains very incomplete. The genetic defects responsible for familial AD influence fibrillogenesis. In a majority of familial cases determined by amyloid precursor protein (APP) and presenilin (PS) mutations, a significant overproduction of Abeta and an increase in the Abeta42/Abeta40 ratio are observed. Recently, it was shown that the two main alloforms of Abeta have distinct biological activity and behaviour at the earliest stage of assembly. In vitro studies demonstrated that Abeta42 monomers, but not Abeta40, form initial and minimal structures (pentamer/hexamer units called paranuclei) that can oligomerize to larger forms. It is now apparent that Abeta oligomers and protofibrils are more neurotoxic than mature Abeta fibrils or amyloid plaques. The neurotoxicity of the prefibrillar aggregates appears to result from their ability to impair fundamental cellular processes by interacting with the cellular membrane, causing oxidative stress and increasing free Ca(2+) that eventually lead to apoptotic cell death.
    MeSH term(s) Alzheimer Disease/metabolism ; Amyloid beta-Peptides/chemistry ; Amyloid beta-Peptides/metabolism ; Amyloid beta-Protein Precursor/chemistry ; Amyloid beta-Protein Precursor/metabolism ; Animals ; Humans ; Models, Biological
    Chemical Substances Amyloid beta-Peptides ; Amyloid beta-Protein Precursor
    Language English
    Publishing date 2005
    Publishing country Poland
    Document type Journal Article ; Review
    ZDB-ID 595762-x
    ISSN 1734-154X ; 0001-527X
    ISSN (online) 1734-154X
    ISSN 0001-527X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Aluminum Phosphate Vaccine Adjuvant: Analysis of Composition and Size Using Off-Line and In-Line Tools.

    Mei, Carmen / Deshmukh, Sasmit / Cronin, James / Cong, Shuxin / Chapman, Daniel / Lazaris, Nicole / Sampaleanu, Liliana / Schacht, Ulrich / Drolet-Vives, Katherine / Ore, Moriam / Morin, Sylvie / Carpick, Bruce / Balmer, Matthew / Kirkitadze, Marina

    Computational and structural biotechnology journal

    2019  Volume 17, Page(s) 1184–1194

    Abstract: Purpose: Aluminum-based adjuvants including aluminum phosphate (AlPO: Methods: This study focuses on the compositional analysis of AlPO: Results: There was no observable difference in size distribution between the intermediate and final stage AlPO! ...

    Abstract Purpose: Aluminum-based adjuvants including aluminum phosphate (AlPO
    Methods: This study focuses on the compositional analysis of AlPO
    Results: There was no observable difference in size distribution between the intermediate and final stage AlPO
    Conclusion: This study demonstrated that in-line PAT can be used to monitor particle size and chemical composition for the various stages of adjuvant manufacturing from raw materials through intermediate to final adjuvant product stage. Similar approaches can be utilized to help assess lot-to-lot consistency during adjuvant manufacturing and vaccine product development. Moreover, the use of in-line PAT is highly conductive to advanced manufacturing strategies such as real-time product release testing and automated processes of the future.
    Language English
    Publishing date 2019-08-21
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2694435-2
    ISSN 2001-0370
    ISSN 2001-0370
    DOI 10.1016/j.csbj.2019.08.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Biophysical Characterization and Thermal Stability of Pneumococcal Histidine Triad Protein D in the Presence of Zinc and Manganese.

    Ausar, Salvador F / Jayasundara, Kavisha / Akawi, Lamees / Roque, Cristopher / Sheung, Anthony / Hu, Jian / Kirkitadze, Marina / Rahman, Nausheen

    Journal of pharmaceutical sciences

    2017  Volume 106, Issue 10, Page(s) 2979–2987

    Abstract: The pneumococcal histidine triad protein D (PhtD) is believed to play a central role ...

    Abstract The pneumococcal histidine triad protein D (PhtD) is believed to play a central role in pneumococcal metal ion homeostasis and has been proposed as a promising vaccine candidate against pneumococcal disease. To investigate for potential stabilizers, a panel of physiologically relevant metals was screened using the thermal shift assay and it was found that only Zn
    MeSH term(s) Adjuvants, Immunologic/chemistry ; Aluminum Hydroxide/chemistry ; Antibodies, Bacterial/chemistry ; Bacterial Proteins/chemistry ; Carrier Proteins/chemistry ; Histidine/chemistry ; Hydrolases/chemistry ; Manganese/chemistry ; Pneumococcal Vaccines/chemistry ; Streptococcus pneumoniae/metabolism ; Tryptophan/chemistry ; Zinc/chemistry
    Chemical Substances Adjuvants, Immunologic ; Antibodies, Bacterial ; Bacterial Proteins ; Carrier Proteins ; Pneumococcal Vaccines ; histidine triad protein ; Manganese (42Z2K6ZL8P) ; Histidine (4QD397987E) ; Aluminum Hydroxide (5QB0T2IUN0) ; Tryptophan (8DUH1N11BX) ; Hydrolases (EC 3.-) ; Zinc (J41CSQ7QDS)
    Language English
    Publishing date 2017-06-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 3151-3
    ISSN 1520-6017 ; 0022-3549
    ISSN (online) 1520-6017
    ISSN 0022-3549
    DOI 10.1016/j.xphs.2017.06.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.

    Kirkitadze, Marina D / Bitan, Gal / Teplow, David B

    Journal of neuroscience research

    2002  Volume 69, Issue 5, Page(s) 567–577

    Abstract: Alzheimer's disease (AD) is a progressive, neurodegenerative disorder characterized by amyloid deposition in the cerebral neuropil and vasculature. These amyloid deposits comprise predominantly fragments and full-length (40 or 42 residue) forms of the ... ...

    Abstract Alzheimer's disease (AD) is a progressive, neurodegenerative disorder characterized by amyloid deposition in the cerebral neuropil and vasculature. These amyloid deposits comprise predominantly fragments and full-length (40 or 42 residue) forms of the amyloid beta-protein (Abeta) organized into fibrillar assemblies. Compelling evidence indicates that factors that increase overall Abeta production or the ratio of longer to shorter forms, or which facilitate deposition or inhibit elimination of amyloid deposits, cause AD or are risk factors for the disease. In vitro studies have demonstrated that fibrillar Abeta has potent neurotoxic effects on cultured neurons. In vivo experiments in non-human primates have demonstrated that Abeta fibrils directly cause pathologic changes, including tau hyperphosphorylation. In concert with histologic studies revealing a lack of tissue injury in areas of the neuropil in which non-fibrillar deposits were found, these data suggested that fibril assembly was a prerequisite for Abeta-mediated neurotoxicity in vivo. Recently, however, both in vitro and in vivo studies have revealed that soluble, oligomeric forms of Abeta also have potent neurotoxic activities, and in fact, may be the proximate effectors of the neuronal injury and death occurring in AD. A paradigm shift is thus emerging that necessitates the reevaluation of the relative importance of polymeric (fibrillar) vs. oligomeric assemblies in the pathobiology of AD. In addition to AD, an increasing number of neurodegenerative disorders, including Parkinson's disease, familial British dementia, familial amyloid polyneuropathy, amyotrophic lateral sclerosis, and prion diseases, are associated with abnormal protein assembly processes. The archetypal features of the assembly-dependent neuropathogenetic effects of Abeta may thus be of relevance not only to AD but to these other disorders as well.
    MeSH term(s) Alzheimer Disease/metabolism ; Amyloid beta-Peptides/chemistry ; Amyloid beta-Peptides/metabolism ; Animals ; Humans ; Mice ; Mice, Transgenic ; Models, Neurological ; Neurodegenerative Diseases/metabolism ; Protein Folding ; Protein Processing, Post-Translational
    Chemical Substances Amyloid beta-Peptides
    Language English
    Publishing date 2002-09-01
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 195324-2
    ISSN 1097-4547 ; 0360-4012
    ISSN (online) 1097-4547
    ISSN 0360-4012
    DOI 10.1002/jnr.10328
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Structure determination of micelle-like intermediates in amyloid beta -protein fibril assembly by using small angle neutron scattering.

    Yong, Winnie / Lomakin, Aleksey / Kirkitadze, Marina D / Teplow, David B / Chen, Sow-Hsin / Benedek, George B

    Proceedings of the National Academy of Sciences of the United States of America

    2002  Volume 99, Issue 1, Page(s) 150–154

    Abstract: Increasing evidence supports the hypothesis that amyloid beta-protein (Abeta) assembly is a key pathogenic feature of Alzheimer's disease. Thus, understanding the assembly process offers opportunities for the development of strategies for treating this ... ...

    Abstract Increasing evidence supports the hypothesis that amyloid beta-protein (Abeta) assembly is a key pathogenic feature of Alzheimer's disease. Thus, understanding the assembly process offers opportunities for the development of strategies for treating this devastating disease. In prior studies, Abeta was found to form micelle-like aggregates under acidic conditions. These structures exhibited an average observed hydrodynamic radius of 7 nm. They were found to be in rapid equilibrium with Abeta monomers or low molecular weight oligomers, and were centers of fibril nucleation. Here the technique of small angle neutron scattering has been used to determine the structure of these Abeta micelles. The data reveal that the micellar assemblies comprise 30-50 Abeta monomers and have elongated geometries. The best fit of the data to a uniform spherocylinder yields a radius approximately 2.4 nm and cylinder length approximately 11 nm. These structure parameters remain constant over more than a decade in concentration range. The concentration independence of the length of the cylindrical aggregate indicates the presence of an internal nonrepetitive structure that spans the entire length of the Abeta assembly.
    MeSH term(s) Amyloid beta-Peptides/chemistry ; Biophysical Phenomena ; Biophysics ; Dose-Response Relationship, Drug ; Hydrogen-Ion Concentration ; Light ; Micelles ; Neutrons ; Peptide Biosynthesis ; Peptide Fragments/chemistry ; Protein Conformation ; Scattering, Radiation ; Time Factors ; Water/chemistry
    Chemical Substances Amyloid beta-Peptides ; Micelles ; Peptide Fragments ; amyloid beta-protein (1-40) ; Water (059QF0KO0R)
    Language English
    Publishing date 2002-01-08
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.012584899
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways.

    Bitan, Gal / Kirkitadze, Marina D / Lomakin, Aleksey / Vollers, Sabrina S / Benedek, George B / Teplow, David B

    Proceedings of the National Academy of Sciences of the United States of America

    2002  Volume 100, Issue 1, Page(s) 330–335

    Abstract: Amyloid beta-protein (Abeta) is linked to neuronal injury and death in Alzheimer's disease (AD). Of particular relevance for elucidating the role of Abeta in AD is new evidence that oligomeric forms of Abeta are potent neurotoxins that play a major role ... ...

    Abstract Amyloid beta-protein (Abeta) is linked to neuronal injury and death in Alzheimer's disease (AD). Of particular relevance for elucidating the role of Abeta in AD is new evidence that oligomeric forms of Abeta are potent neurotoxins that play a major role in neurodegeneration and the strong association of the 42-residue form of Abeta, Abeta42, with the disease. Detailed knowledge of the structure and assembly dynamics of Abeta thus is important for the development of properly targeted AD therapeutics. Recently, we have shown that Abeta oligomers can be cross-linked efficiently, and their relative abundances quantified, by using the technique of photo-induced cross-linking of unmodified proteins (PICUP). Here, PICUP, size-exclusion chromatography, dynamic light scattering, circular dichroism spectroscopy, and electron microscopy have been combined to elucidate fundamental features of the early assembly of Abeta40 and Abeta42. Carefully prepared aggregate-free Abeta40 existed as monomers, dimers, trimers, and tetramers, in rapid equilibrium. In contrast, Abeta42 preferentially formed pentamerhexamer units (paranuclei) that assembled further to form beaded superstructures similar to early protofibrils. Addition of Ile-41 to Abeta40 was sufficient to induce formation of paranuclei, but the presence of Ala-42 was required for their further association. These data demonstrate that Abeta42 assembly involves formation of several distinct transient structures that gradually rearrange into protofibrils. The strong etiologic association of Abeta42 with AD may thus be a result of assemblies formed at the earliest stages of peptide oligomerization.
    MeSH term(s) Alzheimer Disease/pathology ; Amyloid beta-Peptides/biosynthesis ; Amyloid beta-Peptides/isolation & purification ; Amyloid beta-Peptides/metabolism ; Humans ; Models, Neurological ; Molecular Weight ; Peptide Fragments/isolation & purification ; Peptide Fragments/metabolism
    Chemical Substances Amyloid beta-Peptides ; Peptide Fragments ; amyloid beta-protein (1-40) ; amyloid beta-protein (1-42)
    Language English
    Publishing date 2002-12-27
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.222681699
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: A direct interaction between transforming growth factor (TGF)-betas and amyloid-beta protein affects fibrillogenesis in a TGF-beta receptor-independent manner.

    Mousseau, Darrell D / Chapelsky, Sarah / De Crescenzo, Gregory / Kirkitadze, Marina D / Magoon, Joanne / Inoue, Sadayuki / Teplow, David B / O'Connor-McCourt, Maureen D

    The Journal of biological chemistry

    2003  Volume 278, Issue 40, Page(s) 38715–38722

    Abstract: Transforming growth factor-beta (TGF-beta) receptor-mediated signaling has been proposed to mediate both the beneficial and deleterious roles for this cytokine in amyloid-beta protein (Abeta) function. In order to assess receptor dependence of these ... ...

    Abstract Transforming growth factor-beta (TGF-beta) receptor-mediated signaling has been proposed to mediate both the beneficial and deleterious roles for this cytokine in amyloid-beta protein (Abeta) function. In order to assess receptor dependence of these events, we used PC12 cell cultures, which are devoid of TGF-beta receptors. Surprisingly, TGF-beta potentiated the neurotoxic effects of the 40-residue Abeta peptide, Abeta-(1-40), in this model suggesting that there may be a direct, receptor-independent interaction between TGF-beta and Abeta-(1-40). Surface plasmon resonance confirmed that TGF-beta binds with high affinity directly to Abeta-(1-40) and electron microscopy revealed that TGF-beta enhances Abeta-(1-40) oligomerization. Immunohistochemical examination of mouse brain revealed that hippocampal CA1 and dentate gyrus, two regions classically associated with Abeta-mediated pathology, lack TGF-beta Type I receptor immunoreactivity, thus indicating that TGF-beta receptor-mediated signaling would not be favored in these regions. Our observations not only provide for a unique, receptor-independent mechanism of action for TGF-beta, but also help to reconcile the literature interpreting the role of TGF-beta in Abeta function. These data support a critical etiological role for this mechanism in neuropathological amyloidoses.
    MeSH term(s) Amyloid beta-Peptides/metabolism ; Animals ; Binding, Competitive ; Cell Line ; Circular Dichroism ; Densitometry ; Female ; Hippocampus/metabolism ; Immunohistochemistry ; Mice ; Mice, Inbred C3H ; Mice, Inbred C57BL ; Microscopy, Electron ; Neurons/metabolism ; PC12 Cells ; Peptide Fragments/metabolism ; Protein Binding ; Protein Isoforms ; Rats ; Receptors, Transforming Growth Factor beta/metabolism ; Signal Transduction ; Surface Plasmon Resonance ; Time Factors ; Transforming Growth Factor beta/metabolism
    Chemical Substances Amyloid beta-Peptides ; Peptide Fragments ; Protein Isoforms ; Receptors, Transforming Growth Factor beta ; Transforming Growth Factor beta ; amyloid beta-protein (1-40)
    Language English
    Publishing date 2003-07-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.M304080200
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top